TAVER Tablet Ref.[28260] Active ingredients: Carbamazepine

Source: Υπουργείο Υγείας (CY)  Revision Year: 2014  Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Product name and form

TAVER, 200 mg, tablets.

Pharmaceutical Form

Tablet.

For oral administration.

Each tablet is white, round, flat, scored. The tablet can be divided into equal halves.

Qualitative and quantitative composition

Each tablet contains 200 mg carbamazepine.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Carbamazepine

Carbamazepine is a derivative of dibenzazepine. It belongs to the pharmaceutical class of antiepileptic, neurotropic and psychotropic drugs. Carbamazepine helps control the transmission of messages from the brain to the muscles.

List of Excipients

Starch maize, povidone, sodium lauryl sulfate, sodium starch glycollate, powdered cellulose and magnesium stearate.

Pack sizes and marketing

PVC-Alu blisters in carton packs of 50 tablets.

Marketing authorization holder

MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Marketing authorization dates and numbers

7169

20/10/1979

Drugs

Drug Countries
TAVER Cyprus, Hong Kong, Malta, Tunisia

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.